MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab in Combination Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
3Phase III in Spain, 2Phase II in Spain, 1Phase I